Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm
Authors: Melissa D. Simek
Wasima Rida
Frances H. Priddy
Pham Pung
Emily Carrow
Dagna S. Laufer
Jennifer K. Lehrman
Mark Boaz
Tony Tarragona-Fiol
George Miiro
Josephine Birungi
Anton Pozniak
Dale A. McPhee
Olivier Manigart
Etienne Karita
André Inwoley
Walter Jaoko
Jack DeHovitz
Linda Gail Bekker
Punnee Pitisuttithum
Robert Paris
Laura M. Walker
Pascal Poignard
Terri Wrin
Patricia E. Fast
Dennis R. Burton
Wayne C. Koff
International AIDS Vaccine Initiative
Monogram Biosciences
Scripps Research Institute
Emory University
Uganda Virus Research Institute
National Center in HIV-1 Epidemiology and Clinical Research
St Stephen's AIDS Trust
Advanced Bioadjuvants
University of Nairobi
SUNY Downstate Medical Center
University of Cape Town
Mahidol University
Armed Forces Research Institute of Medical Sciences, Thailand
Imperial College London
Sanofi Pasteur
Keywords: Immunology and Microbiology
Issue Date: 1-Jul-2009
Citation: Journal of Virology. Vol.83, No.14 (2009), 7337-7348
Abstract: The development of a rapid and efficient system to identify human immunodeficiency virus type 1 (HIV-1)-infected individuals with broad and potent HIV-1-specific neutralizing antibody responses is an important step toward the discovery of critical neutralization targets for rational AIDS vaccine design. In this study, samples from HIV-1-infected volunteers from diverse epidemiological regions were screened for neutralization responses using pseudovirus panels composed of clades A, B, C, and D and circulating recombinant forms (CRFs). Initially, 463 serum and plasma samples from Australia, Rwanda, Uganda, the United Kingdom, and Zambia were screened to explore neutralization patterns and selection ranking algorithms. Samples were identified that neutralized representative isolates from at least four clade/CRF groups with titers above prespecified thresholds and ranked based on a weighted average of their log-transformed neutralization titers. Linear regression methods selected a five-pseudovirus subset, representing clades A, B, and C and one CRF01-AE, that could identify top-ranking samples with 50% inhibitory concentration (IC50) neutralization titers of > 100 to multiple isolates within at least four clade groups. This reduced panel was then used to screen 1,234 new samples from the Ivory Coast, Kenya, South Africa, Thailand, and the United States, and 1% were identified as elite neutralizers. Elite activity is defined as the ability to neutralize, on average, more than one pseudovirus at an IC50 titer of 300 within a clade group and across at least four clade groups. These elite neutralizers provide promising starting material for the isolation of broadly neutralizing monoclonal antibodies to assist in HIV-1 vaccine design. Copyright © 2009, American Society for Microbiology. All Rights Reserved.
ISSN: 0022538X
Appears in Collections:Scopus 2006-2010

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.